Recombinant human interleukin-1 receptor antagonist (Beijing Beiyi United Biological Engineering)

白细胞介素-1受体拮抗剂（北京北医联合生物）

Report date: 2025/04/07 15:07:19

Base Information

Drug NameRecombinant human interleukin-1 receptor antagonist (Beijing Beiyi United Biological Engineering)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionInterleukin-1 receptor antagonists
TargetsInterleukin-1 receptor
Therapy Area/IndicationsInflammation
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesBeijing Beiyi United Bioengineering Company
China Registration ClassClass 1 therapeutic biologic in China

Develop Information

Active CompaniesBeijing Beiyi United Bioengineering Company
Inactive CompaniesN/A
Active IndicationsInflammation
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A